Title Clinical relevance of Fas expression in oesophageal squamouscell carcinoma

[1]  W. Tan,et al.  Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. , 2004, Journal of the National Cancer Institute.

[2]  K. Chu,et al.  Improvement in Treatment Results and Long-Term Survival of Patients With Esophageal Cancer: Impact of Chemoradiation and Change in Treatment Strategy , 2003, Annals of surgery.

[3]  Remco Dijkman,et al.  A novel splice variant of the Fas gene in patients with cutaneous T-cell lymphoma. , 2002, Cancer research.

[4]  M. Osaki,et al.  Expression of Fas and Fas ligand in esophageal tissue mucosa and carcinomas. , 2002, International journal of oncology.

[5]  D. Scott,et al.  Death the Fas way: regulation and pathophysiology of CD95 and its ligand. , 2000, Pharmacology & therapeutics.

[6]  A. Younes,et al.  Fas ligand expression in esophageal carcinomas and their lymph node metastases , 2000, Cancer.

[7]  M. Tachibana,et al.  Prognostic significance of Fas and Fas ligand expressions in human esophageal cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  C. Brady,et al.  Fas ligand and Fas receptor are coexpressed in normal human esophageal epithelium: a potential mechanism of apoptotic epithelial turnover. , 1999, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[9]  P. Guldberg,et al.  Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. , 1998, Blood.

[10]  C. Brady,et al.  The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma. , 1998, Journal of immunology.

[11]  D. Green,et al.  Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege , 1995, Science.

[12]  H Hengartner,et al.  Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. , 1994, Science.

[13]  K. Sugimachi,et al.  Local immune response to tumor invasion in esophageal squamous cell carcinoma: The expression of human leukocyte antigen‐DR and lymphocyte infiltration , 1994, Cancer.

[14]  S. Law,et al.  The current management of esophageal cancer. , 2007, Advances in surgery.

[15]  P. Hainaut,et al.  Advances in Brief Up-Regulation of Fas ( APO-1 / CD 95 ) Ligand and Down-Regulation of Fas Expression in Human Esophageal Cancer 1 , 2006 .

[16]  M. Saegusa,et al.  Apoptosis and cellular proliferation in oesophageal squamous cell carcinomas: differences between keratinizing and nonkeratinizing types , 2004, Virchows Archiv.

[17]  R. Zinkernagel,et al.  Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. , 1996, Annual review of immunology.